VinaR - Repository of the Vinča Nuclear Institute
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   Vinar
  • Vinča
  • Radovi istraživača
  • View Item
  •   Vinar
  • Vinča
  • Radovi istraživača
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Light controllable TiO2-Ru nanocomposite system encapsulated in phospholipid unilamellar vesicles for anti-cancer photodynamic therapy

No Thumbnail
Authors
Matijević, Milica
Nešić, Maja A.
Stepić, Milutin
Radoičić, Marija B.
Šaponjić, Zoran
Petković, Marijana
Article (Published version)
,
© 2018, Springer Science+Business Media, LLC, part of Springer Nature
Metadata
Show full item record
Abstract
Photodynamic therapy implies a combined use of a photosensitizing medicament and low-intensity light to cause selective damage to the target tissue—tumor. As potential medicament, we use Ru(II)(dcbpy)2Cl2complex, and in order to achieve better photosensitization properties, the Ru complex was attached to the nano carrier—TiO2nanoparticles. Additionally, this nanocomposite system was encapsulated in the phospholipid vesicles, which could be classified as small unilamellar vesicles, based on the technique of production. The complex-release tests were performed under light illumination, at pH 5, characteristic for tumor cells` interior and compared with the release pattern at pH 7, characteristic for the serum, i.e. physiological solution.
Keywords:
photodynamic therapy / light controlled drug release / metallo-drug delivery
Source:
Optical and Quantum Electronics, 2018, 50, 6, 232-
Funding / projects:
  • Mechanistic studies of the reactions of transition metal ion complexes with biologically relevant molecules (RS-172011)
  • Size-, shape- and structure- dependent properties of nanoparticles and nanocomposites (RS-172056)
  • Photonics of micro and nano structured materials (RS-45010)

DOI: 10.1007/s11082-018-1495-z

ISSN: 0306-8919; 1572-817X

WoS: 000433079400001

Scopus: 2-s2.0-85047448688
[ Google Scholar ]
1
1
URI
http://link.springer.com/10.1007/s11082-018-1495-z
https://vinar.vin.bg.ac.rs/handle/123456789/7697
Collections
  • Radovi istraživača
Institution/Community
Vinča
TY  - JOUR
AU  - Matijević, Milica
AU  - Nešić, Maja A.
AU  - Stepić, Milutin
AU  - Radoičić, Marija B.
AU  - Šaponjić, Zoran
AU  - Petković, Marijana
PY  - 2018
UR  - http://link.springer.com/10.1007/s11082-018-1495-z
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/7697
AB  - Photodynamic therapy implies a combined use of a photosensitizing medicament and low-intensity light to cause selective damage to the target tissue—tumor. As potential medicament, we use Ru(II)(dcbpy)2Cl2complex, and in order to achieve better photosensitization properties, the Ru complex was attached to the nano carrier—TiO2nanoparticles. Additionally, this nanocomposite system was encapsulated in the phospholipid vesicles, which could be classified as small unilamellar vesicles, based on the technique of production. The complex-release tests were performed under light illumination, at pH 5, characteristic for tumor cells` interior and compared with the release pattern at pH 7, characteristic for the serum, i.e. physiological solution.
T2  - Optical and Quantum Electronics
T1  - Light controllable TiO2-Ru nanocomposite system encapsulated in phospholipid unilamellar vesicles for anti-cancer photodynamic therapy
VL  - 50
IS  - 6
SP  - 232
DO  - 10.1007/s11082-018-1495-z
ER  - 
@article{
author = "Matijević, Milica and Nešić, Maja A. and Stepić, Milutin and Radoičić, Marija B. and Šaponjić, Zoran and Petković, Marijana",
year = "2018",
abstract = "Photodynamic therapy implies a combined use of a photosensitizing medicament and low-intensity light to cause selective damage to the target tissue—tumor. As potential medicament, we use Ru(II)(dcbpy)2Cl2complex, and in order to achieve better photosensitization properties, the Ru complex was attached to the nano carrier—TiO2nanoparticles. Additionally, this nanocomposite system was encapsulated in the phospholipid vesicles, which could be classified as small unilamellar vesicles, based on the technique of production. The complex-release tests were performed under light illumination, at pH 5, characteristic for tumor cells` interior and compared with the release pattern at pH 7, characteristic for the serum, i.e. physiological solution.",
journal = "Optical and Quantum Electronics",
title = "Light controllable TiO2-Ru nanocomposite system encapsulated in phospholipid unilamellar vesicles for anti-cancer photodynamic therapy",
volume = "50",
number = "6",
pages = "232",
doi = "10.1007/s11082-018-1495-z"
}
Matijević, M., Nešić, M. A., Stepić, M., Radoičić, M. B., Šaponjić, Z.,& Petković, M.. (2018). Light controllable TiO2-Ru nanocomposite system encapsulated in phospholipid unilamellar vesicles for anti-cancer photodynamic therapy. in Optical and Quantum Electronics, 50(6), 232.
https://doi.org/10.1007/s11082-018-1495-z
Matijević M, Nešić MA, Stepić M, Radoičić MB, Šaponjić Z, Petković M. Light controllable TiO2-Ru nanocomposite system encapsulated in phospholipid unilamellar vesicles for anti-cancer photodynamic therapy. in Optical and Quantum Electronics. 2018;50(6):232.
doi:10.1007/s11082-018-1495-z .
Matijević, Milica, Nešić, Maja A., Stepić, Milutin, Radoičić, Marija B., Šaponjić, Zoran, Petković, Marijana, "Light controllable TiO2-Ru nanocomposite system encapsulated in phospholipid unilamellar vesicles for anti-cancer photodynamic therapy" in Optical and Quantum Electronics, 50, no. 6 (2018):232,
https://doi.org/10.1007/s11082-018-1495-z . .

DSpace software copyright © 2002-2015  DuraSpace
About the VinaR Repository | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About the VinaR Repository | Send Feedback

OpenAIRERCUB